Working to find actionable solutions to the nation's key challenges.

Educational Series on Affordable Medicines: Pricing, Repricing, Rebates, and Patient Access

KEYWORDS: EDUCATIONAL SERIES ON AFFORDABLE MEDICINES

WHEN: Wednesday, April 13, 2016 6:00 a.m. to 7:30 a.m. ET

WHERE: Bipartisan Policy Center, 1225 Eye St. NW, Suite 1000, Washington, DC, 20005

Add to Calendar

Event Recap: With Health Care in the Spotlight, Experts Debate Drug Prices

The Bipartisan Policy Center will host three educational forums over the next several months to inform the national conversation on affordable medicines. The purpose of these forums will be to seek an understanding of how private sector decisions and public sector policies impact the prices of drugs and their costs to the health care system. They will highlight what is known about the present system and explore the full range of viewpoints on this issue. BPC hopes each convening will explore how best to support medical innovation while ensuring access and affordability for patients.

The first of these forums addressed how drugs are priced and re-priced, who gets what rebate, and how payer actions impact patient access.


Opening remarks by:

Dr. Jack Hoadley
Research Professor, McCourt School of Public Policy, Georgetown University
View presentation slides

Panel discussion with:

Kirsten Axelsen
Vice President in Worldwide Policy, Pfizer

Mary Dwight
Senior Vice President for Policy and Patient Assistance Programs, Cystic Fibrosis Foundation

Tom Moriarty
Executive Vice President, Chief Health Strategy Officer and General Counsel, CVSHealth

Dr. Edmund Pezalla
Vice President and National Medical Director for Pharmaceutical Policy and Strategy, Aetna

Dr. Wayne Riley
President, American College of Physicians